title: Olmesartan-induced enteropathy.
authors.affiliation: Department of Gastroenterology, Barwon Health, Geelong, Victoria, Australia.
authors.forename: N
authors.initials: N
authors.lastname: Heerasing
authors.forename: C
authors.initials: C
authors.lastname: Hair
authors.forename: S
authors.initials: S
authors.lastname: Wallace
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004378:Duodenal Diseases / Q000139:chemically induced* / Q000175:diagnosis; D004384:Duodenoscopy; D004386:Duodenum / Q000187:drug effects / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000068557:Olmesartan Medoxomil; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles; D000068557:Olmesartan Medoxomil